Pub. Date : 2018 Aug
PMID : 30014256
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | In addition, As2O3-treated epithelial ovarian cancer cells show a decreased VEGFA, VEGFR2 and CD31 mRNA expression. | Arsenic Trioxide | vascular endothelial growth factor A | Homo sapiens |
| 2 | As per the underlying mechanisms involved in As2O3 treatment, we found that As2O3 inhibits VEGFA and VEGFR2 expression that thereby inhibits the VEGFA-VEGFR2-PI3K/ERK signaling pathway. | Arsenic Trioxide | vascular endothelial growth factor A | Homo sapiens |
| 3 | As per the underlying mechanisms involved in As2O3 treatment, we found that As2O3 inhibits VEGFA and VEGFR2 expression that thereby inhibits the VEGFA-VEGFR2-PI3K/ERK signaling pathway. | Arsenic Trioxide | vascular endothelial growth factor A | Homo sapiens |
| 4 | As per the underlying mechanisms involved in As2O3 treatment, we found that As2O3 inhibits VEGFA and VEGFR2 expression that thereby inhibits the VEGFA-VEGFR2-PI3K/ERK signaling pathway. | Arsenic Trioxide | vascular endothelial growth factor A | Homo sapiens |
| 5 | As per the underlying mechanisms involved in As2O3 treatment, we found that As2O3 inhibits VEGFA and VEGFR2 expression that thereby inhibits the VEGFA-VEGFR2-PI3K/ERK signaling pathway. | Arsenic Trioxide | vascular endothelial growth factor A | Homo sapiens |